| Importance of prophages to evolution and virulence of bacterial pathogens LC Fortier, O Sekulovic Virulence 4 (5), 354-365, 2013 | 633 | 2013 |
| PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data JR Garneau, F Depardieu, LC Fortier, D Bikard, M Monot Scientific reports 7 (1), 8292, 2017 | 570 | 2017 |
| Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10 … L Villeneuve, H Girard, LC Fortier, JF Gagné, C Guillemette Journal of Pharmacology and Experimental Therapeutics 307 (1), 117-128, 2003 | 236 | 2003 |
| Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways J Mulhbacher, E Brouillette, M Allard, LC Fortier, F Malouin, ... PLoS pathogens 6 (4), e1000865, 2010 | 210 | 2010 |
| Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver H Girard, O Bernard, LC Fortier, L Villeneuve, Q Hao, DJ Greenblatt, ... Pharmacogenetics and Genomics 14 (8), 501-515, 2004 | 200 | 2004 |
| In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ... MBio 11 (2), 10.1128/mbio. 00019-20, 2020 | 170 | 2020 |
| Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile E Bordeleau, EB Purcell, DA Lafontaine, LC Fortier, R Tamayo, V Burrus Journal of bacteriology 197 (5), 819-832, 2015 | 168 | 2015 |
| Phage production and maintenance of stocks, including expected stock lifetimes LC Fortier, S Moineau Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization …, 2009 | 143 | 2009 |
| c-di-GMP Turn-Over in Clostridium difficile Is Controlled by a Plethora of Diguanylate Cyclases and Phosphodiesterases E Bordeleau, LC Fortier, F Malouin, V Burrus PLoS genetics 7 (3), e1002039, 2011 | 139 | 2011 |
| Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection M Gonzales, J Pepin, EH Frost, JC Carrier, S Sirard, LC Fortier, ... BMC infectious diseases 10, 1-7, 2010 | 135 | 2010 |
| Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens O Sekulovic, M Meessen-Pinard, LC Fortier Journal of bacteriology 193 (11), 2726-2734, 2011 | 130 | 2011 |
| Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes S Sirard, L Valiquette, LC Fortier Journal of clinical microbiology 49 (12), 4040-4046, 2011 | 128 | 2011 |
| Morphological and Genetic Diversity of Temperate Phages in Clostridium difficile LC Fortier, S Moineau Applied and environmental microbiology 73 (22), 7358-7366, 2007 | 127 | 2007 |
| Regulation of stress response in Oenococcus oeni as a function of environmental changes and growth phase J Guzzo, MP Jobin, F Delmas, LC Fortier, D Garmyn, R Tourdot-Maréchal, ... International journal of food microbiology 55 (1-3), 27-31, 2000 | 119 | 2000 |
| Evidence of In Vivo Prophage Induction during Clostridium difficile Infection M Meessen-Pinard, O Sekulovic, LC Fortier Applied and environmental microbiology 78 (21), 7662-7670, 2012 | 115 | 2012 |
| Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile D Gebhart, SR Williams, KA Bishop-Lilly, GR Govoni, KM Willner, A Butani, ... Journal of bacteriology 194 (22), 6240-6247, 2012 | 110 | 2012 |
| The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver H Girard, L Villeneuve, MH Court, LC Fortier, P Caron, Q Hao, ... Drug metabolism and disposition 34 (7), 1220-1228, 2006 | 79 | 2006 |
| Type I toxin-antitoxin systems contribute to the maintenance of mobile genetic elements in Clostridioides difficile J Peltier, A Hamiot, JR Garneau, P Boudry, A Maikova, E Hajnsdorf, ... Communications biology 3 (1), 718, 2020 | 78 | 2020 |
| Function of the CRISPR-Cas system of the human pathogen Clostridium difficile P Boudry, E Semenova, M Monot, KA Datsenko, A Lopatina, O Sekulovic, ... MBio 6 (5), 10.1128/mbio. 01112-15, 2015 | 78 | 2015 |
| Genome Sequence and Global Gene Expression of Q54, a New Phage Species Linking the 936 and c2 Phage Species of Lactococcus lactis LC Fortier, A Bransi, S Moineau Journal of bacteriology 188 (17), 6101-6114, 2006 | 77 | 2006 |
Ognjen SekulovicPfizer, Pearl River, NYDirección de correo verificada de pfizer.com